Skip to main content
. Author manuscript; available in PMC: 2021 Jun 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):272–279. doi: 10.1097/QAI.0000000000002461

Table 3:

Multivariate logistic regression, factors associated with incident HIV diagnoses between enrollment and 12 month follow up, n = 4649a

Estimate aOR 95% CI Pr > ChiSq
Methamphetamine use
 Never users Ref
 Baseline only use 0.81 2.26 0.88 -- 5.78 0.090
 Indicated use between BL and 12M 1.37 3.95 1.64 -- 9.47 0.002
 Persistent methamphetamine use at BL and 12M 1.96 7.11 4.53 -- 11.17 <.0001
Age
 16–24 years old Ref
 25–35 years old 0.12 1.13 0.67 -- 1.91 0.64
 36–45 years old 0.17 1.19 0.65 -- 2.19 0.58
 46–55 years old −0.19 0.83 0.28 -- 2.49 0.74
Race/ethnicity
 White Ref
 Black 1.06 2.88 1.68 -- 4.93 0.0001
 Latino 0.02 1.02 0.61 -- 1.69 0.94
 Asian/Pacific Islander 0.31 1.37 0.48 -- 3.91 0.56
 Other or multiracial 0.42 1.52 0.80 -- 2.87 0.20
Syphilis in the past year
 Yes 0.90 2.47 1.48 -- 4.11 0.001
 No Ref
Incarcerated in the past year
 Yes 0.36 1.43 0.70 -- 2.95 0.33
 No Ref

BL: Baseline (reported at BL with a 3 month recall window), 12M: 12 months (reported at month 12 with a 12 month recall window)

aOR: Adjusted Odds Ratio

a

In order to estimate HIV incidence at 12 months, prevalent HIV cases (n = 137) identified at baseline were excluded.